Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • lamz138138
    Member
    • Mar 2015
    • 10

    #1

    Test significant linkage disequilibrium

    Hi, everyone.

    I had read a paper titled "Multiple Instances of Ancient balancing selection shared between humans and chimpanzees". In the paper, there are 59 human individuals (36 females and 23 males) and 10 chimpanzee (9 females and 1 male). After snps were phased, significant LD were defined as follow: "In humans, we used the phased data provided by paper-1 and applied a Chi-square test, considering a p-value less than 0.005 as significant (i.e., r2 > 0.065) (35). For SNPs lacking phase information, we used the genotype data to calculate r2 and took the same cutoff for significance (r2 > 0.065). In chimpanzees, where the sample size is smaller, we applied Fisher’s exact test to the phased data obtained in paper-2 and regarded a p-value less than 0.1 as significant. For the unphased SNPs on the X chromosome, we applied a Chi-square test to the genotype data, considering a p-value less than 0.1 as significant (i.e., r2 > 0.135). "

    I don't know how the threshold were calculated. I had found a formula by google, Chi-square=N*(r-square), and Chi-square(0.05, df-1)=3.84, since there are 59 individuals, so 3.85/59=0.065, am I right? And what about Fisher's exact test and how it was calculated? And how about X chromosome, since it only have one in male, if using above formula in Chi-square, what is N? Also, whether X chromosome in human and chimpanzee all use Chi-square with p-value less than 0.1 or human use Chi-square while chimpanzee still using Fisher's exact test?

    Thanks for any suggestion!

    Best wishes!
    Last edited by lamz138138; 04-29-2015, 06:42 AM.

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 11:13 AM
0 responses
16 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, Yesterday, 10:48 AM
0 responses
17 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
35 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
42 views
0 reactions
Last Post SEQadmin2  
Working...